Effects of AV 608 on anxiety symptoms and pain rating and brain responses to experimental visceral pain in female patients with irritable bowel syndrome

Trial Profile

Effects of AV 608 on anxiety symptoms and pain rating and brain responses to experimental visceral pain in female patients with irritable bowel syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2012

At a glance

  • Drugs AV 608 (Primary)
  • Indications Irritable bowel syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Jan 2012 Results published in Alimentary Pharmacology and Therapeutics.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top